≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Disorders of synovium and tendon in diseases classified elsewhere

DOID EFO Endpoint Browser PheWeb

M13_SYNOTENDINOTH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

774

4. Check minimum number of events

None

774

5. Include endpoints

None

774

6. Filter based on genotype QC (FinnGen only)

774

Control definitions (FinnGen only)

Control exclude
M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5589 2480 3087
Only index persons 5300 2380 2920
Unadjusted period prevalence (%)
Whole population 0.08 0.07 0.09
Only index persons 0.10 0.09 0.11
Median age at first event (years)
Whole population 53.03 54.84 51.54
Only index persons 52.30 54.19 50.77

-FinnGen-

Key figures

All Female Male
Number of individuals 774 364 410
Unadjusted period prevalence (%) 0.15 0.12 0.18
Median age at first event (years) 53.54 53.45 53.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
687
Matched controls
6870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M71.9
ICD-10 Finland
Bursopathy, unspecified
2627.0
323.0
558
11
M71.8
ICD-10 Finland
Other specified bursopathies
+∞
124.9
116
*
M79.6
ICD-10 Finland
Pain in limb
4.3
57.2
271
908
M75.1
ICD-10 Finland
Rotator cuff syndrome
5.2
50.9
180
440
NHM20
NOMESCO Finland
Excision of synovial ganglion of ankle or foot
75.1
43.6
49
7
M70.2
ICD-10 Finland
Olecranon bursitis
15.7
37.5
62
43
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.8
34.9
350
1870
N02AX02
ATC
tramadol; systemic, rectal
2.6
30.7
316
1671
M01AH05
ATC
etoricoxib; oral
2.6
30.5
428
2692
M25.5
ICD-10 Finland
Pain in joint
2.9
29.6
218
935
M70.6
ICD-10 Finland
Trochanteric bursitis
4.9
27.8
96
219
N03AX16
ATC
pregabalin; oral
3.1
27.5
178
695
M70.4
ICD-10 Finland
Prepatellar bursitis
25.0
27.3
38
16
N03AX12
ATC
gabapentin; oral
3.8
27.1
126
382
M79.0
ICD-10 Finland
Rheumatism, unspecified
78.4
27.0
30
*
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
17.8
27.0
42
25
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.9
26.4
77
144
A46
ICD-10 Finland
Erysipelas
3.5
24.9
130
432
J01DB01
ATC
cefalexin; oral
2.8
24.8
583
4562
J01FF01
ATC
clindamycin; systemic
2.6
24.7
222
1055
M54.5
ICD-10 Finland
Low back pain
2.6
24.1
230
1129
NCM20
NOMESCO Finland
Excision of synovial ganglion of elbow or forearm
129.5
23.7
25
*
S18
ICPC
Laceration/cut
2.3
23.3
305
1754
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.1
23.2
97
266
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
22.7
267
1450
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.7
22.6
81
191
M67.4
ICD-10 Finland
Ganglion
8.4
22.1
49
62
M48.0
ICD-10 Finland
Spinal stenosis
3.8
22.1
99
289
M71.0
ICD-10 Finland
Abscess of bursa
226.8
21.7
22
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.9
21.2
145
576
L17
ICPC
Foot/toe symptom/complaint
2.6
21.1
182
834
L15
ICPC
Knee symptom/complaint
2.7
20.2
155
663
M03BX02
ATC
tizanidine; oral
2.1
20.2
425
2963
NGM20
NOMESCO Finland
Excision of synovial ganglion of knee or lower leg
59.3
20.0
23
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.7
18.8
150
654
A02BC02
ATC
pantoprazole; systemic
2.1
18.7
432
3082
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
7.7
18.5
43
59
M01AE03
ATC
ketoprofen; systemic, rectal
2.2
18.3
259
1502
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
18.1
186
924
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.9
17.9
78
221
J01DA01
ATC
[U] cefalexin; systemic
2.0
17.8
427
3063
M01AB05
ATC
diclofenac; systemic, rectal
2.0
17.2
454
3357
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.6
17.0
135
583
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.9
16.9
73
205
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.9
16.9
109
415
N02BE01
ATC
paracetamol; systemic, rectal
2.3
16.7
574
4715
M71.1
ICD-10 Finland
Other infective bursitis
+∞
16.7
16
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.4
16.0
82
265
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
27.0
15.7
21
8
M03BC01
ATC
orphenadrine (citrate); systemic
2.3
15.2
159
791
M54.4
ICD-10 Finland
Lumbago with sciatica
2.7
15.1
111
456
WX320
NOMESCO Finland
Spinalanesthesy
2.3
15.0
166
847
X58
ICD-10 Finland
Exposure to other specified factors
2.8
14.9
105
421
M79.1
ICD-10 Finland
Myalgia
3.4
14.8
75
240
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.7
14.7
50
112
R06.0
ICD-10 Finland
Dyspnoea
2.3
14.7
160
810
ZXA00
NOMESCO Finland
Right side
2.2
14.6
180
965
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
3.2
14.5
81
278
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
14.5
200
1123
H02AB06
ATC
prednisolone; systemic
1.9
14.2
305
2030
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
14.2
181
982
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
4.5
14.1
50
117
L03
ICPC
Low back symptom/complaint
2.3
14.0
151
757
M79.7
ICD-10 Finland
Fibromyalgia
13.0
14.0
24
19
M01AH02
ATC
rofecoxib; oral
2.8
13.8
97
386
M01AE02
ATC
naproxen; oral, rectal
1.9
13.7
367
2623
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.3
13.6
50
122
L08
ICPC
Shoulder symptom/complaint
2.5
13.5
118
532
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.8
13.4
58
164
M01AH01
ATC
celecoxib; oral (coxibs)
2.4
13.4
121
557
P01BA02
ATC
hydroxychloroquine; oral
3.3
13.3
69
225
M01AC06
ATC
meloxicam; systemic, rectal
1.9
13.0
232
1430
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
13.3
13.0
22
17
M02AA07
ATC
piroxicam; topical
1.9
12.9
231
1425
SPAT1153
SPAT
Removal of sutures
2.0
12.9
216
1303
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.3
12.8
67
220
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.9
12.8
81
301
M13.9
ICD-10 Finland
Arthritis, unspecified
3.6
12.8
59
176
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
12.6
217
1320
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
12.5
185
1059
M01AE01
ATC
ibuprofen; systemic, rectal
2.2
12.5
600
5192
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.8
12.5
84
326
L28
ICPC
Limited function/disability (L)
2.5
12.0
99
431
XA402
NOMESCO Finland
ENMG
7.8
12.0
27
36
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
13.7
12.0
20
15
B01AB05
ATC
enoxaparin; parenteral
1.9
11.9
198
1183
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
5.5
11.8
34
64
N06AA09
ATC
amitriptyline; systemic
3.0
11.6
68
242
P01AB01
ATC
metronidazole; oral, rectal
1.8
11.6
248
1616
J01MA02
ATC
ciprofloxacin; systemic
1.8
11.5
250
1637
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
11.4
328
2351
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
11.2
177
1031
M01AX05
ATC
glucosamine; oral
2.2
11.0
121
606
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.5
11.0
93
409
N06AX21
ATC
duloxetine; oral
2.9
11.0
68
251
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
11.0
69
258
M16.1
ICD-10 Finland
Other primary coxarthrosis
2.7
10.9
78
313
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
10.9
84
352
R03AC02
ATC
salbutamol; inhalant
1.7
10.9
320
2295
A01
ICPC
Pain general/multiple sites
3.4
10.9
53
166
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.6
10.8
78
317
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
10.7
234
1526
M76.6
ICD-10 Finland
Achilles tendinitis
5.0
10.6
33
68
M70.7
ICD-10 Finland
Other bursitis of hip
8.7
10.6
22
26
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.5
10.4
87
381
NFM20
NOMESCO Finland
Excision of bursa of hip or thigh
111.6
10.4
11
*
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
111.6
10.4
11
*
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.2
10.4
55
183
L13
ICPC
Hip symptom/complaint
2.4
10.4
95
438
M01AX17
ATC
nimesulide; oral
2.0
10.4
149
837
R51.80
ICD-10 Finland
Headache
2.4
10.1
86
382
A07EC01
ATC
sulfasalazine; oral, rectal
3.0
10.1
59
211
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
14.8
10.0
16
11
NF1AA
NOMESCO Finland
Hip X-ray examination
2.9
10.0
61
222
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
5.6
9.9
28
52
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
4.3
9.9
36
88
R60.0
ICD-10 Finland
Localized oedema
2.6
9.8
72
294
M70.3
ICD-10 Finland
Other bursitis of elbow
20.4
9.8
14
7
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
9.7
302
2178
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
9.3
9.6
19
21
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.1
9.6
36
91
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
9.5
176
1079
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.0
9.4
55
196
J01CA04
ATC
amoxicillin; systemic
1.7
9.3
518
4380
L10
ICPC
Elbow symptom/complaint
3.8
9.2
38
105
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.9
9.1
54
195
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.7
9.1
62
244
WX110
NOMESCO Finland
Local anesthesy
1.6
9.0
435
3512
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
9.0
433
3490
J01AA02
ATC
doxycycline; systemic
1.7
9.0
495
4144
ZXA05
NOMESCO Finland
Left side
1.9
9.0
153
909
M70.5
ICD-10 Finland
Other bursitis of knee
18.9
9.0
13
7
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
8.9
357
2738
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
8.9
269
1911
NBG10
NOMESCO Finland
Acromioplastia
14.3
8.7
14
10
WX203
NOMESCO Finland
Infraclavicular plexus blockade
6.3
8.7
22
36
N06AX11
ATC
mirtazapine; oral
1.8
8.6
194
1260
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
8.6
95
478
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.5
8.6
67
282
N06AB04
ATC
citalopram; systemic
1.9
8.6
132
758
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
8.6
137
797
C03CA01
ATC
furosemide; systemic
1.8
8.5
159
975
UJF32
NOMESCO Finland
Coloscopy
1.8
8.5
159
975
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.4
8.4
29
68
N02AA05
ATC
oxycodone; systemic
2.2
8.4
87
426
M65.3
ICD-10 Finland
Trigger finger
6.3
8.4
21
34
M68.8
ICD-10 Finland
Other disorders of synovium and tendon in diseases classified elsewhere
+∞
8.3
8
*
M66.0
ICD-10 Finland
Rupture of popliteal cyst
+∞
8.3
8
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
8.7
8.3
17
20
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.5
8.3
63
263
C07AB07
ATC
bisoprolol; oral
1.6
8.3
279
2029
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
8.3
130
751
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
5.0
8.3
25
51
R01AD09
ATC
mometasone; nasal
1.6
8.2
276
2004
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
14.7
8.2
13
9
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
4.4
8.2
28
65
M71.3
ICD-10 Finland
Other bursal cyst
33.8
8.1
10
*
M70.8
ICD-10 Finland
Other soft tissue disorders related to use, overuse and pressure
33.8
8.1
10
*
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
17.4
8.1
12
7
M71.5
ICD-10 Finland
Other bursitis, not elsewhere classified
22.3
8.0
11
5
R4120
NOMESCO Finland
Occupational therapy
3.1
8.0
43
146
N06AX16
ATC
venlafaxine; oral
2.2
7.9
85
420
ZXE00
NOMESCO Finland
One hour or less
1.6
7.9
242
1712
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
3.7
7.9
33
93
A02BC05
ATC
esomeprazole; systemic
1.6
7.8
244
1732
L12
ICPC
Hand/finger symptom/complaint
2.2
7.8
81
396
L01
ICPC
Neck symptom/complaint
2.2
7.8
80
387
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.9
7.8
45
160
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
4.7
7.8
25
55
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
7.7
106
580
WX200
NOMESCO Finland
Interscalenous plexus blockade
6.0
7.7
20
34
NHL16
NOMESCO Finland
Tenolysis or tenosynovectomy of achilles tendon
45.5
7.7
9
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
7.7
96
505
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
7.7
235
1659
A02BC03
ATC
lansoprazole; oral
1.7
7.5
176
1153
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
7.5
168
1086
R07.3
ICD-10 Finland
Other chest pain
2.4
7.4
60
260
R05
ICD-10 Finland
Cough
1.9
7.4
114
653
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
9.5
7.3
14
15
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
9.5
7.3
14
15
7261X
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]
+∞
7.3
7
*
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.7
7.3
23
50
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
7.3
141
873
S19
ICPC
Skin injury other
3.4
7.2
33
100
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
3.9
7.2
28
74
205
Kela drug reimbursment
Chronic hypertension
1.7
7.2
169
1106
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.5
7.2
24
55
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
7.2
268
1985
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
3.6
7.2
30
85
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
20.3
7.1
10
5
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
6.1
7.1
18
30
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
5.7
7.1
19
34
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
8.9
7.1
14
16
TQW40
NOMESCO Finland
Remowal of suture of skin
2.6
7.1
50
203
R42
ICD-10 Finland
Dizziness and giddiness
1.9
7.0
118
692
S80.0
ICD-10 Finland
Contusion of knee
3.0
7.0
40
140
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
5.0
7.0
21
43
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
4.5
7.0
23
52
G47.3
ICD-10 Finland
Sleep apnoea
1.8
7.0
139
866
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
7.0
116
680
L88
ICPC
Rheumatoid/seropositive arthritis
3.7
6.9
28
77
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
6.9
51
210
KMAK
NOMESCO Finland
NA
1.5
6.9
310
2391
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
3.6
6.9
29
83
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
3.7
6.8
28
78
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
6.8
99
551
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.1
6.8
25
63
A02BC01
ATC
omeprazole; systemic
1.7
6.8
161
1053
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
11.1
6.8
12
11
R02
ICPC
Shortness of breath/dyspnoea
2.2
6.8
67
321
J01MA12
ATC
levofloxacin; systemic
1.8
6.8
121
727
ZX140
NOMESCO Finland
Intra articular
16.9
6.8
10
6
A04
ICPC
Weakness/tiredness general
2.1
6.8
73
363
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.7
184
1254
S21
ICPC
Skin texture symptom/complaint
2.1
6.7
75
380
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
6.7
230
1660
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
4.3
6.7
23
55
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.0
6.6
25
65
Z01.2
ICD-10 Finland
Dental examination
1.6
6.6
237
1729
R4110
NOMESCO Finland
Physiotherapy
1.7
6.6
159
1047
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
12.4
6.6
11
9
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
12.4
6.6
11
9
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
8.8
6.6
13
15
WX002
NOMESCO Finland
Sedation and analgesia
1.8
6.6
121
736
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
6.6
150
974
M54.3
ICD-10 Finland
Sciatica
3.0
6.6
35
120
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
3.8
6.5
26
71
H04.10
ICD-10 Finland
Dry eye syndrome
2.4
6.5
55
245
M02AA10
ATC
ketoprofen; topical
1.9
6.5
93
518
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.6
6.4
45
180
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.8
6.4
20
43
E0000UV
ATC
NA
1.6
6.4
235
1718
M20.2
ICD-10 Finland
Hallux rigidus
3.8
6.4
25
67
Z3226
NOMESCO Finland
Physiotherapist
1.9
6.4
103
597
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.5
6.4
28
83
M54.2
ICD-10 Finland
Cervicalgia
2.7
6.4
42
164
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.1
6.4
70
349
M47.82
ICD-10 Finland
Other spondylosis, cervical region
3.6
6.4
27
78
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.3
6.4
22
53
K02.1
ICD-10 Finland
Caries of dentine
1.5
6.3
335
2663
AN1
HP
Coronary angiography
2.1
6.3
70
353
Z01.9
ICD-10 Finland
Special examination, unspecified
2.8
6.3
38
141
M47.9
ICD-10 Finland
Spondylosis, unspecified
4.4
6.3
21
49
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
2.9
6.3
36
128
M67.0
ICD-10 Finland
Short Achilles tendon (acquired)
+∞
6.3
6
*
7290A
ICD-9 Finland
Other disorders of soft tissues, Rheumatism, unspecified and fibrositis
+∞
6.3
6
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
6.2
311
2437
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
7.1
6.2
14
20
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
6.2
176
1208
SPAT1254
SPAT
Administration of medicine
2.0
6.2
79
419
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
6.2
136
870
M54.6
ICD-10 Finland
Pain in thoracic spine
2.8
6.2
38
143
H02AB04
ATC
methylprednisolone; systemic
1.9
6.2
87
482
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.7
6.2
40
154
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
4.3
6.2
21
50
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
2.6
6.1
43
173
J01FA06
ATC
roxithromycin; oral
1.5
6.1
240
1781
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
2.2
6.1
62
301
M77.4
ICD-10 Finland
Metatarsalgia
3.4
6.1
27
81
UKC02
NOMESCO Finland
Cystoscopy
1.9
6.1
95
543
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
6.1
69
352
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.5
6.1
342
2746
M54
ICD-10 Finland
Dorsalgia
2.1
6.1
66
328
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.7
6.1
40
156
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
8.7
6.1
12
14
Z00.0
ICD-10 Finland
General medical examination
1.8
6.0
105
625
I49.5
ICD-10 Finland
Sick sinus syndrome
3.9
6.0
23
61

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
216
782
3.44
47.69
2.3
2.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
73
109
7.29
47.45
1.7
1.7
e6/l
20154.4
15186.0
0.22
53
82
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
71
127
6.05
38.67
1.6
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
48
69
7.35
32.12
1.4
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
50
79
6.70
30.68
1.9
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
272
1519
2.22
23.05
2.7
2.7
umol/l
1526.8
9052.8
3.89
236
1320
(3023368) Bacteria identified in Blood by Culture
274
1562
2.17
21.82
4.6
4.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
146
650
2.54
20.56
2.0
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
572
4374
2.18
19.90
5.6
3.6
mm/h
12.8
11.9
0.67
539
4015
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
166
823
2.29
18.23
1.3
1.2
u/ml
19.1
13.0
0.42
70
318
(3024263) Appearance of Synovial fluid
21
23
9.36
17.38
2.1
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
304
1945
1.93
16.61
7.5
5.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
53
149
3.75
16.56
1.9
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
166
865
2.17
15.96
1.4
1.2
iu/ml
32.7
32.0
0.03
53
279
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
28
52
5.55
14.57
2.3
1.5
%
51.4
56.8
0.26
19
37
(3010144) Erythrocytes [#/volume] in Synovial fluid
26
45
5.94
14.54
1.7
1.3
e6/l
73932.8
7084.4
0.61
21
29
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
385
2737
1.81
14.47
4.8
4.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
260
1654
1.86
13.94
2.6
2.0
u/l
156.2
304.6
1.66
240
1540
(3006315) Basophils [#/volume] in Blood
406
2961
1.78
13.75
8.1
5.5
e9/l
0.0
0.0
1.62
364
2551
(3037522) Nuclear Ab [Titer] in Serum
138
707
2.16
13.70
1.4
1.3
titre
375.8
547.2
0.88
38
137
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
207
1230
1.93
13.65
1.9
1.6
mg/l
1.1
1.2
0.48
156
926
(3022096) Basophils/100 leukocytes in Blood
377
2701
1.77
13.48
8.2
5.8
%
0.7
0.7
0.01
355
2523
(3001604) Monocytes [#/volume] in Blood
403
2945
1.77
13.44
8.0
5.5
e9/l
0.6
0.6
1.05
361
2533
(3013115) Eosinophils [#/volume] in Blood
414
3050
1.77
13.41
8.5
5.9
e9/l
0.2
0.2
0.97
372
2681
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
574
4680
1.88
12.98
8.7
7.5
u/l
80.3
78.1
0.48
550
4407
(3019198) Lymphocytes [#/volume] in Blood
408
3016
1.75
12.86
8.1
5.6
e9/l
2.0
1.9
0.35
367
2645
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
394
2889
1.74
12.74
8.7
7.1
mmol/l
1.2
1.2
1.56
337
2425
(3006504) Eosinophils/100 leukocytes in Blood
382
2783
1.74
12.59
8.3
5.7
%
2.9
2.8
0.13
361
2595
(3019069) Monocytes/100 leukocytes in Blood
383
2802
1.73
12.35
8.6
6.1
%
8.5
8.8
1.16
363
2627
(3032080) INR in Blood by Coagulation assay
338
2391
1.73
12.29
9.8
9.3
inr
1.3
1.3
0.02
101
719
(3018010) Neutrophils/100 leukocytes in Blood
384
2822
1.72
12.10
8.0
5.6
%
59.2
57.2
2.93
364
2651
(3013650) Neutrophils [#/volume] in Blood by Automated count
451
3473
1.72
11.88
9.9
9.1
e9/l
4.7
4.1
2.20
407
3037
(3013826) Glucose [Moles/volume] in Serum or Plasma
456
3535
1.71
11.60
5.2
4.8
mmol/l
6.9
6.7
0.58
427
3288
(3002030) Lymphocytes/100 leukocytes in Blood
386
2866
1.69
11.51
8.4
5.8
%
25.8
27.9
3.68
365
2678
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
700
6198
2.35
11.47
20.5
12.9
mg/l
22.8
25.2
1.13
608
4785
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
105
3.65
11.42
1.7
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
509
4080
1.72
11.30
5.4
3.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
387
2907
1.66
10.79
4.3
3.2
estimate
0.0
0.0
0.00
70
511
(3021601) Nitrite [Presence] in Urine by Test strip
382
2867
1.66
10.64
5.6
4.4
estimate
0.0
0.0
0.50
75
536
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
355
2617
1.66
10.59
6.5
6.2
mmol/l
1.2
1.2
0.46
315
2368
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
323
2326
1.67
10.54
2.1
1.9
pmol/l
98.5
94.7
0.73
177
1226
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
37
5.52
10.44
2.3
1.3
%
28.4
28.6
0.01
13
23
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
214
1387
1.75
10.26
2.4
2.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
380
2872
1.63
10.12
4.3
3.2
estimate
0.0
0.0
0.00
66
525
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
549
4555
1.71
10.10
4.6
3.7
pmol/l
14.8
14.8
0.04
504
4111
(3019309) Folate [Moles/volume] in Red Blood Cells
168
1023
1.82
9.91
1.8
1.7
nmol/l
1196.8
1182.1
0.07
117
757
(3044640) Blood type and Crossmatch panel - Blood
265
1849
1.66
9.56
2.5
2.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
640
5578
1.85
9.54
5.3
4.4
mu/l
1.9
1.9
0.12
598
5073
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
21
45
4.77
9.34
1.0
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
303
2210
1.61
9.03
4.1
3.3
ng/l
41.7
36.6
0.31
222
1515
(3022217) INR in Platelet poor plasma by Coagulation assay
125
720
1.88
8.74
21.7
22.2
inr
1.3
1.2
0.23
21
105
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
207
1386
1.67
8.60
2.7
2.0
mg/l
3.0
3.0
0.02
174
1156
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
396
3102
1.57
8.54
5.5
6.7
umol/l
12.2
11.7
0.17
369
2961
(3005719) IgG [Mass/volume] in Serum or Plasma
88
453
2.06
8.50
2.1
2.5
g/l
10.4
10.7
0.41
80
412
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
254
1796
1.62
8.49
2.8
2.5
u/l
54.9
58.3
0.44
235
1670
(3025941) Bacteria identified in Stool by Culture
64
291
2.31
8.41
1.3
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
334
2533
1.56
8.21
6.1
5.1
g/l
34.8
35.7
1.77
309
2366
(3009445) Proteinase 3 Ab [Units/volume] in Serum
54
232
2.43
8.06
1.3
1.5
—
10.6
—
0
7
(3023103) Potassium [Moles/volume] in Serum or Plasma
712
6518
2.15
7.95
21.5
15.1
mmol/l
4.0
4.0
0.25
703
6326
(3026008) Bacteria identified in Urine by Culture
230
1624
1.59
7.59
4.2
2.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
304
2290
1.54
7.53
2.6
2.2
nmol/l
77.0
76.5
0.11
276
2066
(3021589) Normoblasts [#/volume] in Blood
352
2739
1.52
7.49
11.6
9.0
e9/l
0.1
0.0
0.50
295
2245
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
75
382
2.07
7.45
1.8
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
708
6497
2.05
7.39
21.2
14.9
mmol/l
139.5
139.7
0.78
698
6315
(3001122) Ferritin [Mass/volume] in Serum or Plasma
323
2477
1.52
7.30
3.4
2.6
ug/l
117.0
146.9
2.09
295
2280
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
179
1203
1.63
7.19
1.2
1.2
u/ml
1.3
1.8
0.35
44
324
(3045414) Leukocytes [Presence] in Urine
50
221
2.35
7.03
1.9
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
678
6155
1.82
7.02
4.7
4.3
mmol/l
5.9
5.9
0.08
617
5614
(3018677) aPTT in Platelet poor plasma by Coagulation assay
141
896
1.70
7.00
1.9
2.0
s
29.9
29.7
0.12
135
864
(40761511) CBC panel - Blood by Automated count
711
6561
2.03
6.88
18.3
12.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
138
880
1.69
6.76
3.6
2.6
umol/l
12.1
13.7
1.75
122
816
(3000850) Epithelial cells [#/volume] in Urine
176
1201
1.60
6.59
3.4
2.4
e6/l
4.1
5.6
0.83
155
1056
(3018418) pH of Serum or Plasma
238
1740
1.53
6.58
4.9
4.0
ph
7.4
7.4
0.67
39
330
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
190
2.40
6.53
1.6
1.9
g/l
3.2
3.2
0.20
28
151
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
224
1619
1.54
6.52
2.6
3.0
ng/l
2320.4
1340.1
0.98
194
1383
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
203
2.35
6.50
1.6
1.8
g/l
7.3
7.4
0.10
29
154
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
42
178
2.44
6.49
1.5
1.6
iu/ml
0.1
0.1
0.05
15
25
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
14
29
4.90
6.47
1.5
1.3
u/l
3.9
5.4
2.04
14
22
(3004588) Protein electrophoresis panel - Serum or Plasma
69
363
1.99
6.29
1.5
2.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
264
1989
1.50
6.28
3.5
3.3
u/l
31.3
32.9
0.39
246
1896
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
62
314
2.06
6.27
1.9
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
272
2068
1.49
6.16
4.8
3.3
e6/l
88.5
81.3
0.07
212
1457
(3021960) Folate [Moles/volume] in Serum or Plasma
187
1313
1.56
6.15
1.6
1.5
nmol/l
20.2
20.5
0.09
165
1121
(3004789) Transferrin [Mass/volume] in Serum or Plasma
128
820
1.67
6.13
3.7
2.5
g/l
2.3
2.3
0.37
114
760
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
203
2.29
6.07
1.6
1.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
203
2.29
6.07
1.6
1.8
g/l
4.0
3.9
0.23
27
148
(3019150) Specific gravity of Urine by Refractometry
178
1240
1.57
6.06
4.6
3.6
kg/l
1.0
1.0
0.21
23
181
(3000494) Fungus identified in Specimen by Culture
111
687
1.72
6.04
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
211
1530
1.52
5.98
5.0
3.6
estimate
0.0
0.0
0.80
70
513
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
137
900
1.63
5.95
2.2
1.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
275
2112
1.47
5.86
4.1
3.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
110
685
1.71
5.85
5.2
8.7
mmol/l
1.1
1.2
0.12
79
539
(3048689) Calprotectin [Mass/mass] in Stool
106
655
1.72
5.80
2.2
2.4
ug/g
105.3
147.8
1.42
84
526
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
114
2.70
5.79
1.3
1.2
e6/l
14.8
4.4
0.55
25
86
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
30
114
2.70
5.79
1.4
1.3
e6/l
188.1
211.5
0.07
25
91
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
288
2244
1.45
5.64
4.6
3.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
119
766
1.65
5.58
9.3
6.6
mmol/l
1.1
1.0
0.46
112
712
(3025159) Blasts/100 leukocytes in Blood
78
446
1.83
5.55
5.1
4.2
%
0.6
0.1
0.42
15
116
(40768804) Tissue Pathology biopsy report
298
2343
1.44
5.54
2.0
2.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
696
6456
1.77
5.50
5.2
4.7
mmol/l
2.7
2.8
0.74
642
5963
(3041096) Erythrocytes [Presence] in Urine by Automated
217
1608
1.49
5.47
3.7
2.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
720
6759
1.94
5.31
13.3
9.8
u/l
28.0
27.5
0.32
703
6508
(3017143) Hepatitis C virus Ab [Presence] in Serum
101
631
1.69
5.30
1.7
1.7
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
107
679
1.67
5.30
5.3
8.7
kpa
11.8
12.2
0.36
96
648
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
107
679
1.67
5.30
5.3
8.7
kpa
5.0
5.1
0.79
97
645
(3020630) Protein [Mass/volume] in Serum or Plasma
77
447
1.80
5.22
2.8
2.6
g/l
65.9
66.8
0.43
68
410
(40761535) Cells panel - Urine sediment
78
455
1.79
5.21
4.5
3.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
18
54
3.39
5.19
1.6
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
98
611
1.69
5.19
2.7
2.6
%
1.7
1.7
0.04
87
550
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
36
159
2.33
5.12
1.7
1.7
g/l
37.8
37.1
0.23
26
139
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
187
2.20
4.99
1.6
1.8
g/l
8.8
10.5
2.38
29
162
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
136
933
1.56
4.88
1.5
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
78
464
1.76
4.88
5.2
4.2
%
0.2
0.1
0.27
16
133
(3002179) Metamyelocytes/100 leukocytes in Blood
76
449
1.77
4.87
4.4
4.0
%
0.8
0.5
0.26
13
110
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
14
37
3.84
4.83
1.1
1.0
mg/l
49.3
40.1
—
9
29
(3011397) Hemoglobin [Presence] in Urine by Test strip
177
1289
1.48
4.80
4.4
3.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
683
6351
1.64
4.73
4.8
4.3
mmol/l
4.6
4.7
0.41
636
5911
(4027681)
13
33
3.99
4.72
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
159
1137
1.50
4.71
3.4
2.5
mosm/kgh2o
528.6
568.2
1.26
137
970
(3023520) Reticulocytes [#/volume] in Blood
76
454
1.75
4.69
3.1
2.8
e9/l
69.0
68.3
0.06
65
351
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
115
768
1.58
4.64
3.9
2.6
%
20.9
23.8
1.62
91
652
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
147
2.30
4.63
1.3
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
743
7090
2.20
4.62
28.7
18.9
e9/l
256.3
248.6
2.37
734
6886
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
16
48
3.38
4.62
1.6
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
81
495
1.71
4.62
5.1
4.1
%
1.4
0.9
0.32
16
146
(3002582) Erythrocytes [#/volume] in Urine
230
1772
1.42
4.62
4.3
2.9
e6/l
45.9
105.0
0.82
191
1361
(3024731) MCV [Entitic volume]
743
7092
2.19
4.59
28.6
18.8
fl
91.3
91.1
0.86
738
6969
(3035941) MCH [Entitic mass]
743
7093
2.19
4.57
28.6
18.8
pg
30.4
30.4
0.20
738
6968
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
148
2.28
4.56
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
63
359
1.82
4.56
3.9
3.5
ph
7.4
7.4
—
10
50
(3026361) Erythrocytes [#/volume] in Blood
743
7094
2.18
4.55
28.7
18.9
e12/l
4.5
4.5
0.15
735
6872
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
13
34
3.87
4.55
1.0
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
743
7095
2.18
4.53
28.7
18.9
e9/l
7.1
6.7
3.89
734
6872
(3000963) Hemoglobin [Mass/volume] in Blood
743
7096
2.18
4.51
28.8
19.0
g/l
136.6
137.1
0.41
738
6970
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
36
169
2.19
4.47
1.7
2.1
g/l
0.2
1.3
2.03
27
149
(3016502) Oxygen saturation in Arterial blood
94
604
1.63
4.44
5.7
9.3
%
94.9
95.6
0.39
86
579
(3033658) Prothrombin time (PT) actual/Normal
199
1503
1.44
4.43
4.4
3.8
%
90.9
89.8
0.24
190
1468
(42529406) Shigella sp [Presence] in Stool by Culture
33
150
2.25
4.43
1.3
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
80
495
1.69
4.37
2.8
2.9
ng/l
107.2
186.8
2.60
71
447
(3002032) Base excess in Venous blood by calculation
87
551
1.65
4.35
4.3
3.5
mmol/l
1.8
2.2
0.43
71
428
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
439
3790
1.37
4.34
2.9
2.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
678
6321
1.59
4.32
4.7
4.2
mmol/l
1.4
1.4
1.56
630
5843
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
158
1148
1.47
4.30
4.3
3.5
ng/l
324.6
532.5
0.54
127
916
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
60
344
1.81
4.27
3.8
3.5
mmol/l
1.6
1.8
0.19
48
253
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
72
436
1.72
4.25
6.7
4.0
ng/l
109.6
86.3
1.00
64
386
(3044290) Cell count panel - Cerebral spinal fluid
25
102
2.50
4.25
1.4
1.3
—
—
—
0
0
(3012544) pH of Venous blood
88
563
1.64
4.23
4.1
3.5
—
7.4
—
0
5
(3007164) IgA [Mass/volume] in Serum or Plasma
153
1109
1.47
4.21
1.3
1.4
g/l
2.8
2.5
1.01
95
709
(40768797) Stomach Pathology biopsy report
114
777
1.55
4.20
1.3
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
27
4.12
4.17
1.0
1.0
u/l
0.9
1.1
—
5
19
(3013512) EKG study
219
1700
1.40
4.15
4.7
3.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
17
57
3.03
4.14
1.0
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
209
1614
1.40
4.07
4.1
2.8
e6/l
0.2
0.6
4.28
165
1210
(3009214) Lutropin [Units/volume] in Serum or Plasma
33
156
2.17
4.05
1.4
1.3
u/l
8.6
8.1
0.09
28
125
(3016018) Differential panel - Cerebral spinal fluid
15
48
3.17
3.94
1.4
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
137
986
1.47
3.90
3.2
2.5
e6/l
1.4
1.0
0.50
90
569
(4010399)
68
416
1.70
3.89
1.4
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
49
272
1.86
3.88
3.7
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
26
114
2.33
3.82
4.5
3.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
114
794
1.51
3.81
1.6
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
94
630
1.56
3.74
2.0
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
468
4132
1.34
3.72
3.8
3.1
u/l
64.3
51.9
0.66
436
3853
(46235355) HIV 1 and 2 tests - Meaningful Use set
135
979
1.46
3.69
1.8
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
98
665
1.54
3.69
1.4
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
57
337
1.75
3.69
2.6
2.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
214
1686
1.37
3.65
1.6
1.6
mmol/l
1.4
1.4
0.40
178
1413
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
655
6112
1.47
3.62
4.3
3.8
mmol/l
1.4
1.3
2.44
607
5628
(3020682) Albumin/Creatinine [Ratio] in Urine
237
1901
1.36
3.60
5.1
4.0
mg/mmol
16.9
8.4
1.03
163
1228
(36304419) Bacteria [Presence] in Urine
200
1563
1.38
3.58
3.7
2.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
31
152
2.08
3.50
1.4
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
6
10.06
3.50
3.8
1.5
ng/l
254.2
167.0
—
6
6
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
35
181
1.98
3.44
1.9
3.0
mg/l
40.8
36.5
0.25
27
144
(3034860) Kappa light chains.free [Mass/volume] in Serum
35
181
1.98
3.44
1.9
3.0
mg/l
44.3
54.3
0.45
27
141
(3022313) Gas panel - Capillary blood
45
254
1.82
3.41
3.2
3.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
85
571
1.55
3.36
5.9
9.5
g/l
124.1
123.1
0.18
77
545
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
95
654
1.52
3.36
4.0
4.4
u/l
241.5
240.1
0.04
84
620
(40758558) Short blood count panel - Blood
191
1497
1.37
3.34
7.5
6.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
23
102
2.29
3.32
2.0
2.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
34
177
1.96
3.29
1.9
3.0
ratio
1.1
1.2
—
5
12
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
71
460
1.60
3.28
4.8
2.7
ml/min/173m2
63.6
65.8
0.15
31
174
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
54
2.81
3.27
1.3
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
28
136
2.10
3.26
1.5
3.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
223
1796
1.34
3.26
3.9
3.2
mg/l
877.8
297.0
0.65
158
1154
(3017446) Testosterone [Moles/volume] in Serum or Plasma
83
561
1.54
3.20
2.4
2.1
nmol/l
13.1
13.6
0.21
73
502
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
23
104
2.25
3.18
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
96
671
1.49
3.16
3.1
2.8
umol/l
8.2
8.8
0.10
80
589
(36660697) Celiac disease serology panel - Serum
65
416
1.61
3.16
1.1
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
111
2.20
3.15
4.9
3.2
%
62.0
57.4
0.72
24
111
(3009508) Creatinine [Moles/volume] in Urine
235
1915
1.33
3.15
4.5
3.2
mmol/l
7.3
8.0
1.48
199
1626
(3012095) Magnesium [Moles/volume] in Serum or Plasma
130
965
1.42
3.13
3.3
3.7
mmol/l
0.8
0.8
0.33
119
910
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
163
1259
1.37
3.11
1.9
1.7
pmol/l
385.5
22526352.5
0.99
134
1061
(4062490)
14
50
2.83
3.10
1.4
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
40
225
1.82
3.08
2.2
2.0
—
—
—
0
0
(4024509)
11
34
3.27
3.06
1.4
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
125
927
1.42
3.02
3.5
2.7
e6/l
2.2
2.2
0.02
79
513
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
57
2.66
2.98
1.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
37
206
1.84
2.96
2.0
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
172
1350
1.35
2.95
5.8
4.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
75
506
1.53
2.92
6.6
8.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
95
2.24
2.92
1.2
1.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
638
5982
1.38
2.91
17.5
12.0
ml/min/173m2
79.9
81.6
1.11
568
4904
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
30
3.36
2.91
1.1
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
90
633
1.48
2.88
2.0
1.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
13
5.42
2.87
1.7
1.4
ug/l
8.5
8.5
—
7
13
(3002385) Erythrocyte distribution width [Ratio]
573
5292
1.32
2.86
24.1
15.9
%
13.7
13.7
0.28
561
5159
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
158
1.93
2.84
2.8
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
55
349
1.62
2.79
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
21
97
2.20
2.79
1.9
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
495
4493
1.28
2.77
4.2
3.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
33
182
1.85
2.73
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
105
2.13
2.71
4.9
3.0
e9/l
5.2
4.2
0.89
22
105
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
10
6.04
2.70
1.2
5.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
12
43
2.82
2.65
1.2
1.1
titre
74.0
280.0
—
5
6
(3019225) pH of Specimen
76
526
1.49
2.65
6.2
4.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
23
113
2.07
2.64
5.1
4.8
mmol/l
2.3
2.2
0.06
15
67
(3008152) Bicarbonate [Moles/volume] in Arterial blood
59
387
1.57
2.62
5.8
7.9
mmol/l
25.0
24.4
0.50
51
358
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
107
2.09
2.59
1.6
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
107
2.09
2.59
1.6
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
7
7.18
2.55
1.2
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
7
7.18
2.55
1.2
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
11
5.49
2.54
2.0
2.2
mmol/l
1.2
1.2
—
6
11
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
72
500
1.49
2.48
2.7
2.3
ug/l
9.2
8.6
0.07
59
443
(3024928) Oxygen saturation in Venous blood
24
123
1.98
2.47
2.2
2.8
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
45
2.69
2.46
1.1
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
39
235
1.69
2.43
3.0
2.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
285
2452
1.26
2.40
4.8
4.5
ug/l
1.9
2.9
1.53
269
2195
(3000492) Spirometry study
83
597
1.44
2.40
1.4
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
132
1.92
2.38
1.6
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
8
6.28
2.37
3.2
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
48
308
1.60
2.36
2.0
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
41
253
1.66
2.35
2.6
2.1
ug/l
5.5
1.3
0.75
35
222
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
39
238
1.67
2.33
1.6
1.8
g/l
1.6
1.6
0.09
31
203
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
86
626
1.42
2.33
4.1
3.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
17
78
2.21
2.32
1.4
1.3
pmol/l
263.9
290.9
0.21
12
66
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
10
35
2.88
2.31
1.0
1.3
u/ml
0.0
1.4
—
5
19
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
34
201
1.72
2.28
1.5
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
58
394
1.51
2.24
4.2
6.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
620
5854
1.30
2.20
6.7
5.5
mmol/mol
40.2
39.7
0.70
575
5433
(3047181) Lactate [Moles/volume] in Blood
35
211
1.69
2.20
4.2
8.6
mmol/l
1.2
1.4
0.78
29
185
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
24
3.36
2.18
2.4
2.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
18
87
2.09
2.18
1.3
1.9
g/l
1.3
0.9
0.42
12
64
(3004716) Salmonella sp identified in Stool by Organism specific culture
42
267
1.61
2.16
1.5
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
19
3.71
2.15
1.4
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
55
2.39
2.13
1.5
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
49
2.47
2.11
1.4
1.3
g/l
7.7
7.1
—
6
30
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
49
2.47
2.11
1.4
1.3
g/l
2.8
2.7
—
6
29
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
49
2.47
2.11
1.4
1.3
g/l
0.3
0.3
—
6
29
(4306422)
17
82
2.10
2.08
1.1
1.2
—
—
—
0
0
(4133840)
6
15
4.02
2.04
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
32
2.83
2.00
1.0
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
227
1938
1.24
1.99
2.8
3.7
mmol/l
2.3
2.4
0.34
192
1710
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
21
3.35
1.97
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
20
106
1.91
1.92
1.5
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
21
114
1.87
1.88
2.6
2.7
%
17.5
16.7
0.39
13
64
(3017732) Neutrophils [#/volume] in Blood
54
376
1.47
1.88
3.3
3.8
e9/l
4.7
4.2
0.69
41
297
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
49
335
1.49
1.87
6.7
12.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
80
2.02
1.81
1.2
1.2
u/ml
1.4
5.4
—
5
26
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
39
256
1.55
1.79
3.8
7.5
%
1.7
1.7
0.15
34
239
(3042111) Morphology [Interpretation] in Bone marrow Narrative
20
109
1.86
1.78
1.5
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
13
60
2.19
1.78
1.5
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
55
390
1.44
1.76
1.4
1.2
iu/ml
121.5
139.3
0.25
27
153
(3011648) Oxygen content in Venous blood
10
41
2.46
1.76
2.8
1.8
%
11.5
11.5
—
10
41
(3028707) Methadone [Presence] in Urine by Screen method
15
74
2.05
1.76
11.3
2.8
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
6
18
3.35
1.75
1.0
1.1
ng/l
—
633.2
—
0
6
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
210
1.60
1.73
2.2
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
98
767
1.32
1.73
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
61
2.15
1.72
1.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
42
2.40
1.68
1.2
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
26
157
1.68
1.67
3.5
3.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
19
3.17
1.66
1.3
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
65
483
1.38
1.62
5.0
3.9
mmol/l
1.2
1.2
0.88
51
414
(3004616) Nuclear Ab [Presence] in Serum
12
56
2.16
1.61
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
84
1.92
1.60
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
167
1.64
1.60
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
99
1.84
1.58
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
37
250
1.50
1.53
3.9
7.5
%
0.9
0.9
0.21
32
233
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
15
3.35
1.52
1.2
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
21
2.87
1.51
1.3
1.8
%
167.0
119.0
—
6
21
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
21
2.87
1.51
3.0
4.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
65
2.02
1.49
2.4
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
147
1.65
1.49
7.3
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
101
812
1.28
1.48
1.5
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
38
2.38
1.46
1.3
1.9
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
50
363
1.40
1.44
3.5
2.8
g/l
127.0
131.5
0.66
50
354
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
22
2.74
1.43
1.0
1.1
iu/ml
256.1
286.9
—
6
22
(3009542) Hematocrit [Volume Fraction] of Blood
612
5856
1.22
1.42
20.3
13.9
%
40.7
40.3
0.44
417
4262
(3016879) Cocaine [Presence] in Urine
27
173
1.58
1.42
6.8
1.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
126
1.69
1.41
3.0
2.1
u/l
24.9
1203.0
—
6
51
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
119
1.70
1.39
2.1
2.3
g/l
137.9
132.6
0.40
14
93
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
37
0.00
1.34
0.0
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
49
656
0.73
1.34
1.2
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
144
1.62
1.33
1.3
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
55
415
1.35
1.28
1.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
186
1.52
1.28
6.6
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
55
2.01
1.28
1.3
2.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
187
1.52
1.25
6.7
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
71
559
1.30
1.25
2.9
2.2
u/l
44.6
42.6
0.05
56
490
(3037756) Immunofixation for Serum or Plasma
20
124
1.63
1.21
1.3
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
19
2.64
1.21
1.6
3.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
96
789
1.25
1.20
1.9
1.9
%
1.5
1.5
0.27
81
685
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
206
1.47
1.19
3.5
2.7
u/ml
0.4
0.3
0.27
19
117
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
26
2.32
1.19
2.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
8
38
2.12
1.18
1.0
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
79
1.79
1.17
1.2
1.2
u/ml
2.3
4.8
—
7
28
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
102
1.68
1.17
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
158
1.54
1.16
1.3
1.5
ug/g
279.6
293.7
0.13
16
89
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
15
87
1.74
1.15
6.1
4.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
15
87
1.74
1.15
1.6
4.1
%
1.3
0.9
—
10
73
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
72
1.82
1.15
1.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
36
259
1.41
1.13
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
80
1.76
1.13
2.2
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
151
1.54
1.12
1.5
1.9
iu/l
285.1
4.7
0.46
11
56
(4146454)
11
58
1.91
1.12
2.2
2.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
58
1.91
1.12
1.2
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
24
160
1.52
1.10
4.0
3.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
47
612
0.75
1.10
1.7
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
21
2.39
1.09
1.2
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
7
32
2.20
1.08
1.9
1.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
32
2.20
1.08
1.0
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
70
562
1.27
1.08
1.9
2.3
g/l
0.2
0.2
0.20
61
529
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
59
1.88
1.07
2.8
3.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
27
186
1.47
1.07
6.8
1.8
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
33
2.13
1.05
1.1
1.2
nmol/l
179.9
143.9
—
7
33
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
67
1.80
1.05
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
64
511
1.28
1.04
5.2
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
46
1.97
1.04
1.6
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
31
222
1.41
1.02
1.5
1.3
iu/l
27.5
27.9
0.02
26
187
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
14
83
1.70
1.02
1.1
1.3
—
0.6
—
0
7
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
107
1.60
1.00
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
9
49
1.85
0.99
1.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
23
2.18
0.98
1.6
12.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
100
1.61
0.97
1.3
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
85
710
1.22
0.95
5.2
4.3
%
30.9
31.3
0.11
62
467
(3014271) Vancomycin [Susceptibility]
6
27
2.23
0.93
3.7
2.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
55
1.83
0.92
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
13
78
1.68
0.92
1.2
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
63
1.76
0.90
1.4
4.7
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
217
1972
1.14
0.88
4.2
4.0
%
21.2
21.2
0.01
101
893
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
20
136
1.48
0.87
1.4
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
30
2.01
0.87
1.0
1.0
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
6
30
2.01
0.87
26.3
28.4
ug/l
6.9
7.3
—
6
25
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
196
1.39
0.85
1.4
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
30
223
1.36
0.83
1.2
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
11
65
1.70
0.82
1.8
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
122
1.49
0.80
1.8
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
288
1.30
0.77
2.7
2.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
16
107
1.51
0.76
3.4
3.1
nmol/l
0.8
0.9
0.27
11
83
(3008037) Lactate [Moles/volume] in Venous blood
19
132
1.45
0.76
3.6
2.8
mmol/l
1.5
1.6
0.20
19
127
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
185
0.64
0.76
1.3
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
91
1.55
0.75
1.2
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
38
1.85
0.73
1.7
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
159
1.39
0.73
1.8
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
25
2.01
0.72
1.6
4.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
39
1.80
0.72
1.9
1.7
—
—
—
0
0
(4268621)
9
56
1.61
0.72
2.4
2.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
84
1.56
0.72
1.4
1.6
—
—
—
0
0
(3039000) Anion gap in Blood
21
151
1.40
0.72
4.4
10.4
mmol/l
11.6
11.5
0.03
16
135
(3018572) Chloride [Moles/volume] in Blood
21
151
1.40
0.72
4.4
10.4
mmol/l
104.8
104.9
0.06
16
135
(3027944) Amphetamines [Presence] in Urine
25
186
1.36
0.71
1.3
1.7
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
26
1.93
0.70
1.0
2.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
93
1.51
0.70
1.4
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
69
1.60
0.68
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
42
1.67
0.68
1.4
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
57
678
0.83
0.68
1.5
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
78
1.55
0.66
1.2
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
44
1.60
0.65
4.6
4.1
u/ml
17.8
48.3
—
7
44
(3021901) Oxygen saturation in Capillary blood
17
120
1.43
0.65
2.4
2.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
81
704
1.17
0.63
7.0
6.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
30
1.67
0.61
1.0
4.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
2.0
1.7
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
16
113
1.42
0.61
1.8
1.4
u/ml
113.2
109.6
—
6
17
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
80
1.51
0.60
1.4
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
14
97
1.45
0.59
6.4
5.3
umol/l
292.2
377.4
1.56
14
81
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
64
1.57
0.58
1.5
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
53
1.51
0.58
1.1
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
75
653
1.16
0.58
2.8
4.7
ug/l
8.8
34.5
1.14
59
528
(3023419) Bacteria identified in Sputum by Culture
11
73
1.51
0.56
2.1
3.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
73
1.51
0.56
2.6
2.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
55
1.46
0.56
1.1
1.1
nmol/l
1.2
1.4
—
8
50
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
1.5
1.6
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
14
99
1.42
0.54
1.0
1.1
g/l
1.3
1.5
1.80
14
88
(3022806) Fractional oxyhemoglobin in Capillary blood
10
66
1.52
0.52
2.2
2.0
%
90.5
89.3
—
10
66
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
63
1.43
0.52
1.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
63
1.43
0.52
1.6
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
63
1.43
0.52
6.3
2.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
63
1.43
0.52
1.6
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
100
0.60
0.52
1.3
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
100
0.60
0.52
1.3
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
100
0.60
0.52
1.3
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
100
0.60
0.52
1.3
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.6
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
64
1.41
0.51
1.6
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
67
1.50
0.50
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
76
1.45
0.48
1.0
1.0
u/ml
5.6
2.5
—
5
28
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
155
1.30
0.47
2.7
2.3
ug/min
103.5
107.7
—
10
89
(3020891) Body temperature
27
218
1.25
0.47
3.4
4.1
—
—
—
0
0
(4034850)
24
191
1.26
0.47
6.5
8.7
—
—
—
0
0
(4035726)
64
563
1.15
0.46
1.3
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
7
49
1.43
0.46
1.6
2.2
—
33.0
—
0
7
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
69
1.46
0.44
1.0
1.0
u/ml
2.6
2.2
—
5
25
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
95
1.37
0.44
1.1
1.1
u/ml
5.2
3.0
—
5
36
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
31
1.62
0.43
1.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
31
1.62
0.43
2.0
1.8
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
57
1.41
0.42
1.6
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
58
1.38
0.41
2.4
3.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
33
1.52
0.41
1.0
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
33
1.52
0.41
1.4
2.7
u/ml
529.6
1573.7
—
5
33
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
25.2
—
0
16
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
0.3
—
0
11
(3008536) Aspergillus sp Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
20
159
1.26
0.40
1.5
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
13
97
1.35
0.39
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
55
486
1.14
0.39
1.9
1.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
12
89
1.35
0.38
1.1
2.7
u/ml
414.4
144.2
0.26
12
83
(3001019) Free T4 and TSH panel - Serum or Plasma
27
322
0.83
0.38
1.6
1.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
13
98
1.33
0.37
1.7
2.9
—
477.9
—
0
8
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
153
1435
1.08
0.37
3.1
2.8
ug/l
0.6
0.7
2.72
102
910
(3037121) Protein [Mass/volume] in Urine
26
217
1.21
0.36
4.0
3.9
g/l
0.2
0.2
0.04
17
97
(44790047)
5
76
0.66
0.36
1.2
1.7
—
—
—
0
0
(44806118)
5
76
0.66
0.36
1.2
1.7
—
—
—
0
0
(44790048)
5
76
0.66
0.36
1.2
1.7
—
—
—
0
0
(44790049)
5
76
0.66
0.36
1.2
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
42
1.43
0.35
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
61
547
1.13
0.35
2.0
1.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
10
73
1.37
0.34
5.1
3.1
%
13.4
13.1
—
10
73
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
44
1.37
0.34
2.2
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
11
82
1.35
0.34
1.1
1.0
u/ml
1.1
4.5
—
5
19
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
82
1.35
0.34
3.2
2.2
pg
31.7
32.7
0.37
11
82
(3011288) Drugs identified in Urine by Screen method
16
127
1.27
0.33
13.9
3.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
46
1.31
0.33
1.5
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
88
0.68
0.33
1.5
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
83
1.33
0.32
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
16
128
1.26
0.32
1.9
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
11
84
1.31
0.30
2.2
1.9
mmol/l
1.5
1.6
0.19
11
84
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
109
0.73
0.29
1.4
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
76
1.32
0.28
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
63
1.27
0.28
1.0
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
19
159
1.20
0.27
1.1
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
67
1.20
0.26
2.0
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
77
1.30
0.26
1.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
72
0.69
0.26
1.2
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
73
0.68
0.26
2.4
2.5
—
—
—
0
0
(4281824)
5
73
0.68
0.26
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
11
138
0.79
0.25
2.5
3.6
mg/l
21.2
28.0
—
6
85
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
83
0.72
0.24
1.0
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
85
0.70
0.24
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
85
0.70
0.24
1.3
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
18
152
1.19
0.24
2.1
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
125
0.80
0.23
1.3
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.9
—
17.4
—
0
11
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.3
—
1.6
—
0
6
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
7
60
1.17
0.18
1.0
1.0
—
0.2
—
0
11
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
61
1.15
0.17
2.6
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
16
184
0.87
0.17
1.7
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
152
0.85
0.17
1.6
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
158
1.14
0.16
1.7
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
162
0.86
0.16
1.6
1.3
miu/ml
127.2
235.8
—
8
67
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
76
0.79
0.15
1.8
3.4
nmol/l
14.3
5.4
—
6
76
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
20
178
1.13
0.15
1.8
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
7
90
0.78
0.14
1.0
1.4
mmol/l
5.4
7.3
—
7
64
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
19
170
1.12
0.13
1.0
1.1
—
5.5
—
0
21
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
106
0.85
0.13
1.9
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
107
0.84
0.13
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
108
0.83
0.13
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
148
0.88
0.12
1.6
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
104
1.16
0.12
1.4
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
243
2477
0.97
0.12
3.2
2.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
11
126
0.87
0.11
1.1
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
28
261
1.08
0.10
1.0
1.1
titre
—
80.7
—
0
9
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
38
402
0.94
0.10
1.3
1.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
44
1.14
0.10
4.8
4.9
—
53.1
—
0
17
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
56
1.07
0.08
1.7
2.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
28
263
1.07
0.08
2.0
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.2
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
144
0.90
0.08
1.6
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
65
0.77
0.08
1.2
2.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
65
1.08
0.08
2.6
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
70
0.86
0.07
1.2
2.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
83
0.84
0.07
1.4
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
54
521
1.04
0.07
1.4
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
91
0.88
0.06
2.0
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
207
1.06
0.06
2.2
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
177
1749
1.02
0.05
1.5
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
129
0.93
0.03
1.8
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
26
252
1.03
0.02
1.4
1.8
mg/l
3.3
3.5
0.08
21
185
(1002224) Polysomnography panel
28
273
1.03
0.01
1.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
106
1054
1.01
0.00
2.6
3.2
mmol/l
2.5
2.4
0.62
93
935
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
12
116
1.04
0.00
1.2
1.1
iu/ml
17.4
13.5
—
5
25
(4094501)
19
186
1.02
0.00
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
47
465
1.01
0.00
1.6
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
122
0.98
0.00
1.8
1.1
u/ml
410.3
248.7
—
6
75
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
122
0.98
0.00
1.8
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
3.4
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
6
0.00
0.00
0.0
2.5
—
143.8
—
0
6
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
88
0.91
0.00
1.4
1.2
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
7.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
6
68
0.88
0.00
1.3
1.4
nmol/l
0.2
0.3
—
6
56
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
50
1.00
0.00
1.2
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
51
0.98
0.00
1.2
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
89
1.01
0.00
1.2
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
62
0.97
0.00
2.2
9.1
mmol/l
6.7
6.9
—
6
54
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
6.9
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SYNOTENDINOTH and mortality.

Females

Parameter HR [95% CI] p-value
M13_SYNOTENDINOTH 1.148 [0.98, 1.35] 0.091
Birth year 0.994 [0.99, 1.0] 0.143

During the follow-up period (1.1.1998 — 31.12.2019), 339 out of 2095 females with M13_SYNOTENDINOTH died.

Males

Parameter HR [95% CI] p-value
M13_SYNOTENDINOTH 1.269 [1.11, 1.45] < 0.001
Birth year 0.987 [0.98, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 486 out of 2633 males with M13_SYNOTENDINOTH died.

Mortality risk

Mortality risk for people of age

years, who have M13_SYNOTENDINOTH.

N-year risk Females Males
1 0.1% 0.256%
5 0.619% 1.539%
10 1.6% 3.883%
15 3.072% 7.347%
20 5.635% 11.901%

Relationships between endpoints

↥

Index endpoint: M13_SYNOTENDINOTH – Disorders of synovium and tendon in diseases classified elsewhere

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data